2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)

• Yokota S,
• Imagawa T,
• Miyamae T,
• Kasai K,
• Mori M,
• Nishimoto N,
• Kishimoto T

Affiliations

Yokota S

Imagawa T

Miyamae T

Kasai K

Mori M

Nishimoto N

Kishimoto T